GL1X · GenesisL1 explorer

Research workbench

MALT1 in complex with compound 1

Analyse MALT1 in complex with compound 1 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7PAW
Type
protein
Length
713 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mucosa-associated lymphoid tissue lymphoma translocation protein 1
EC
3.4.22.-
UniProt
Q9UDY8
Ligands
6IT
Pockets
9 · best druggability 0.84

Structure

x-ray diffraction · 2 distinct chains · 24% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-)protein34623% helix, 26% strandQ9UDY8
BMucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-)protein36725% helix, 27% strandQ9UDY8

Ligands and binding sites

  • 6IT · ~{N}1-(3-chloranyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-~{N}4-[2-(trifluoromethyl)pyrimidin-4-yl]cyclohexane-1,4-diamine · ligand · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13770.840.9352empty
22480.720.86346IT
32060.610.8237empty
41640.540.8031empty
52160.530.7726empty

Interfaces

1 interface between chains.

  • A–B · 1446 Ų buried · 15 hydrogen bonds · protein-protein

Compared structures

  • 7PAW · MALT1 in complex with compound 1 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9UDY8 · AlphaFold monomer V2.0 prediction for mucosa-associated lymphoid tissue lymphoma… · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.